Posts

"At least one" lesson in claim construction from Australia

Australian Federal Court finds biosimilar etanercept manufacturing processes do not infringe Pfizer's ENBREL process patent

[Book Review] Patent Claims: Interpretation, validity and infringement

Alexion's Soliris sequence error saga (Alexion v Samsung Bioepis [2025] EWHC 1240)

The UPC's approach to added matter and functional claims (Abbott v. Sibio Technology, UPC_CoA_382/2024)

[UPCKat] UPC Court of Appeal’s PI ruling leaves open the possibility of using prosecution history as an aid for claim construction

[Guest Post] Is this the end of patent claim construction as we know it?

Birss J excuses Chugai from tocilizumab royalties in UCB "validity tie breaker"

Around the IP blogs!